Scheme for Conservation, Development and Sustainable Management of Medicinal Plants
- The outreach and acceptability of AYUSH systems, both nationally as well as globally, are dependent on uninterrupted availability of quality medicinal plants based raw material
“PSIR Answer Writing” course visit www.upschacks.com
- More than 90% of the species use d in trade continue to be sourced from the wild of which about 2/3 rd are harvested by destructive means.
- Development and cultivation of medicinal plants has been hence been covered as a component under the Centrally Sponsored Scheme of National AYUSH Mission.
Strategies
- To adopt an end- to-end approach covering production, post harvest management, processing and marketing. This will be achieved by promoting cultivation of medicinal plants in identified clusters within selected districts of states having potential for medicinal plants cultivation and to promote such cultivation following Good Agricultural and Collection Practices (GACPs) through synergistic linkage with production and supply of quality planting material, processing, quality testing, certification, warehousing and marketing for meeting the demands of the AYUSH industry and for exports of value added items.
- To promote medicinal plants as a crop alternative to the farmers and through increased coverage of medicinal plants and with linkages for processing, marketing and testing, offer remunerative prices to the growers/farmers.
- This will also reduce pressure on forests on account of wild collection.
- To adopt communication through print and electronic media as a strong component of its strategy to promote integration of medicinal plants farming in the agriculture/horticulture systems with emphasis on quality and standardization through appropriate pre and post harvest linkages.
- To promote and support collective efforts at cultivation and processing in clusters through Self Help Groups, growers cooperatives/associations, producer companies and such other organizations with strong linkages to manufacturers/traders and R&D institutions.


